Melanoma Clinical Trial

Patient Preference for Biopsy Notification

Summary

Effective communication between physician and patient is fundamental to effective care. The recent introduction of electronic patient on-line portals has the potential to change the communication landscape. The investigators surveyed patients to assess their preferred modality for biopsy notification at 3 institutions with differing patient access to on-line portals, to ascertain what patient preferences are currently and if it has changed from historical preferences. Our hypothesis is that as patients become more familiar with ln-line portals, their preferences will likely reflect familiarity with this modality.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who were 18 years of age or older and English speaking were eligible to participate

Exclusion Criteria:

Younger than 18, non-English speaking.

Study is for people with:

Melanoma

Estimated Enrollment:

301

Study ID:

NCT02213471

Recruitment Status:

Completed

Sponsor:

Maria Wei

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California
San Francisco California, 94115, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

301

Study ID:

NCT02213471

Recruitment Status:

Completed

Sponsor:


Maria Wei

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider